DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - News

 
 



News related to Revlimid (Lenalidomide) and/or conditions it is approved for

REVLIMID approved by the European Commission for the treatment of adult patients with previously untreated multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.31]
Celgene International Sà€rl, a wholly owned subsidiary of Celgene Corporation, has announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult...

FDA approves Kyprolis (carfilzomib) for combination use In the treatment of patients with relapsed multiple myeloma
Source: Blood / Hematology News From Medical News Today [2015.07.27]
Amgen has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with...

Poor survival in multiple myeloma patients linked to genetic variation
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.23]
As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die...

NY-ESO-1 TCR-engineered T-cells demonstrate durable persistence, clinical activity and tolerability in clinical study in multiple myeloma patients
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.21]
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, has announced that data from its Phase I/II study of its affinity...

T-cell receptor therapy achieves encouraging clinical responses in multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.21]
NY-ESO T cell receptor therapy found to be safe, with no cytokine release syndrome casesResults from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own...

Multiple Myeloma
Source: MedicineNet cyclophosphamide Specialty [2015.04.30]
Title: Multiple Myeloma
Category: Symptoms and Signs
Created: 4/30/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM

Study links leisure time sitting to higher risk of specific cancers
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.07.14]
Spending more leisure time sitting was associated with a higher risk of total cancer risk in women, and specifically with multiple myeloma, breast, and ovarian cancers, according a new study.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015